Glenmark Pharmaceuticals Inc. has been granted abbreviated new drug application (ANDA) approval by the US Food & Drug Administration (USFDA) for its Abiraterone Acetate tablets USP, 250 mg, a generic…Read More
Cipla has acquired a patented anti-infective drug Elores from Venus Remedies Ltd. The product is used for the treatment of life-threatening infections caused by certain bacteria. The company feels that…Read More
Sun Pharma’s subsidiary has launched Drizalma Sprinkle in the US. It is the first and only USFDA-approved sprinkle formulation of Drizalma Sprinkle, which is delayed-release duloxetine capsules used in treatment…Read More
GlaxoSmithKline plc has announced a five-year collaboration with Lyell Immunopharma to develop new technologies to improve cell therapies for cancer patients. The collaboration will apply Lyell’s technologies to further strengthen…Read More
Shield Healthcare has acquired Brio Bliss Life Science and Nutri Synapzz Therapeutics. Following the acquisitions, Shield Healthcare aims to increase its presence in gynecology and pediatrics. Brio Bliss Life Science…Read More
Granules India Ltd. has decided to divest its entire equity shareholding in its Chinese joint venture, Granules Biocause Pharmaceuticals. The latter is an equal joint venture between Granules India and…Read More
Cipla’s net profit has increased by 6 percent during the June quarter to Rs 478.19 crore. The company had also posted a profit of Rs 451.25 crore during the year-ago…Read More
Cadila Healthcare Ltd. has reported a net profit of Rs 79 crore for the quarter ended June 2019, a sharp decline by about 75 percent from Rs 310 crore in…Read More
Sun Pharma Industries Ltd. has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and commercialize seven generic products in Mainland China. The…Read More
Lonza India with turnover of 100 million CHF (Swiss Franc) has set the target of doubling its turnover by 2024 with an estimated growth of more than 15 percent. The…Read More
Cadila Healthcare’s manufacturing facility Alidac Pharmaceuticals Ltd. (Alidac), located at Pharmez, Ahmedabad, has received an establishment inspection report (EIR). The USFDA had conducted a pre-approval inspection (PAI) for doxorubicin liposomal,…Read More
Aurobindo Pharma Limited will invest up to USD 200 million on CapEx and over 5 percent of sale value on research and development (R&D) during the current financial year. The…Read More
India Alternatives Investment Advisors Ltd. has invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited. Among the fastest-growing companies in the Indian pharmaceutical market,…Read More
The board of Alembic Pharmaceuticals has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis. The company will issue NCDs…Read More
